Dr Reddys Laboratories (RDY) Research & Development (2009 - 2023)

Dr Reddys Laboratories' Research & Development history runs 15 years deep, the most recent figure standing at $66.0 million for Q2 2023.

• On a quarterly basis, Research & Development changed N/A year-over-year to $66.0 million in Q2 2023; TTM through Jun 2023 was $251.0 million, a N/A change from a year earlier, with the FY2026 full-year figure at $256.0 million, down 20.0% from the prior year.
• Research & Development rose to $66.0 million in Q2 2023 per RDY's latest filing, from $60.0 million in the prior quarter.
• Across five years, Research & Development topped out at $66.0 million in Q2 2023 and bottomed at $51.0 million in Q2 2019.
• The 5-year median for Research & Development is $60.0 million (2020), against an average of $58.8 million.
• Across the five-year window, Research & Development fell 12.07% in 2019 and rose 17.65% in 2020, its largest moves.
• Year by year, Research & Development stood at $55.0 million in 2019, then rose by 1.82% to $56.0 million in 2020, then rose by 7.14% to $60.0 million in 2021, then grew by 8.33% to $65.0 million in 2022, then gained by 1.54% to $66.0 million in 2023.
• Per Business Quant, the three latest RDY Research & Development figures stand at $66.0 million (Q2 2023), $60.0 million (Q1 2023), and $65.0 million (Q4 2022).